GGrantIndex
← Leaderboards

Xiongwei Zhu

Case Western Reserve University

$20,338,249
Attributed
$24,229,062
Total exposure
15
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,229,062 · 15

By mechanism

RF1$10,250,445 · 4
R01$9,751,391 · 6
P30$2,372,843 · 3
T32$1,427,343 · 1
R21$427,040 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseasePlayNeuronsPathogenesisMediatingNerve DegenerationIn VivoMitochondriaAffectMitochondrial DysfunctionBrainDefectCellsMouse ModelIn VitroSynapsesNeurodegenerative DisordersBaseOverexpressionTrainingProteinsNeuronal DysfunctionRegulation

Grant awards (48)

Role of PDE2A in mitochondrial dysfunction in Alzheimer’s disease$721,300
R01 · FY2025 · AG
Regulation of mitochondrial DNA homeostasis and neuroinflammation by Fascin in Alzheimer’s Disease$693,640
R01 · FY2025 · AG
Research Education Component$405,067
P30 · FY2025 · AG · contact PI
Training in Neurodegenerative Diseases$239,629
T32 · FY2025 · NS · contact PI
Role of PDE2A in mitochondrial dysfunction in Alzheimer’s disease$752,468
R01 · FY2024 · AG
Research Education Component$515,946
P30 · FY2024 · AG · contact PI
Training in Neurodegenerative Diseases$167,887
T32 · FY2024 · NS · contact PI
Training in Neurodegenerative Diseases$1,080
T32 · FY2024 · NS · contact PI
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease$2,156,262
RF1 · FY2023 · AG · contact PI
Role of PDE2A in mitochondrial dysfunction in Alzheimer’s disease$764,388
R01 · FY2023 · AG
Research Education Component$398,636
P30 · FY2023 · AG · contact PI
Training in Neurodegenerative Diseases$161,105
T32 · FY2023 · NS · contact PI
Administrative supplement to Regulation of mitochondrial DNA homeostasis and neuroinflammation by Fascin$84,679
RF1 · FY2023 · AG
Regulation of mitochondrial DNA homeostasis and neuroinflammation by Fascin in Alzheimer’s Disease$2,187,498
RF1 · FY2022 · AG
Role of PDE2A in mitochondrial dysfunction in Alzheimer’s disease$789,176
R01 · FY2022 · AG
Research Education Component$299,345
P30 · FY2022 · AG · contact PI
Training in Neurodegenerative Diseases$156,756
T32 · FY2022 · NS · contact PI
Role of PDE2A in mitochondrial dysfunction in Alzheimer's disease$799,872
R01 · FY2021 · AG
Research Education Component$232,065
P30 · FY2021 · AG · contact PI
Training in Neurodegenerative Diseases$146,937
T32 · FY2021 · NS · contact PI
Research Education Component$337,510
P30 · FY2020 · AG · contact PI
Training in Neurodegenerative Diseases$145,265
T32 · FY2020 · NS · contact PI
Research Education Component$184,274
P30 · FY2019 · AG · contact PI
Training in Neurodegenerative Diseases$143,632
T32 · FY2019 · NS · contact PI
The Role of PGC-1alpha and Mitochondrial Biogenesis in the Pathogenesis of Alzheimer's Disease$3,192,507
RF1 · FY2018 · AG · contact PI
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise$415,237
R01 · FY2017 · NS · contact PI
Training in Neurodegenerative Diseases$80,749
T32 · FY2017 · NS · contact PI
Molecular Mechanisms Underlying Mitochondrial Dynamics Abnormalities in Alzheimer Disease$2,629,499
RF1 · FY2016 · AG · contact PI
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise$415,237
R01 · FY2016 · NS · contact PI
Training in Neurodegenerative Diseases$92,644
T32 · FY2016 · NS · contact PI
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise$415,237
R01 · FY2015 · NS · contact PI
Epigenomic Mechanism of Parkinson's Disease$201,912
R01 · FY2015 · NS · contact PI
Training in Neurodegenerative Diseases$91,659
T32 · FY2015 · NS · contact PI
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise$411,086
R01 · FY2014 · NS · contact PI
Epigenomic Mechanism of Parkinson's Disease$199,894
R01 · FY2014 · NS · contact PI
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise$415,237
R01 · FY2013 · NS · contact PI
Epigenomic Mechanism of Parkinson's Disease$201,912
R01 · FY2013 · NS · contact PI
Mitochondrial Fission and Fusion in Alzheimer Disease$306,269
R01 · FY2012 · AG · contact PI
Mitochondrial Fission and Fusion in Alzheimer Disease$306,269
R01 · FY2011 · AG · contact PI
LRRK2 and mitochondrial dysfunction$230,790
R21 · FY2011 · NS · contact PI
Mitochondrial Fission and Fusion in Alzheimer Disease$318,632
R01 · FY2010 · AG · contact PI
LRRK2 and mitochondrial dysfunction$196,250
R21 · FY2010 · NS · contact PI
Mitochondrial Fission and Fusion in Alzheimer Disease$321,850
R01 · FY2009 · AG · contact PI
Metal Ion is Critical in amyloid beta Induced JNK Activation$241,111
R01 · FY2009 · AG · contact PI
Mitochondrial Fission and Fusion in Alzheimer Disease$320,141
R01 · FY2008 · AG · contact PI
Metal Ion is Critical in amyloid beta Induced JNK Activation$241,111
R01 · FY2008 · AG · contact PI
Metal Ion is Critical in amyloid beta Induced JNK Activation$246,032
R01 · FY2007 · AG · contact PI
Metal Ion is Critical in amyloid beta Induced JNK Activation$253,380
R01 · FY2006 · AG · contact PI